EUR 13.06
(1.08%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 597.52 Million EUR | -4.23% |
2022 | 623.89 Million EUR | 14.26% |
2021 | 546.05 Million EUR | 6.86% |
2020 | 510.99 Million EUR | 20.2% |
2019 | 425.11 Million EUR | 4.39% |
2018 | 407.24 Million EUR | 22.47% |
2017 | 332.51 Million EUR | -12.64% |
2016 | 380.61 Million EUR | -3.73% |
2015 | 395.35 Million EUR | 28.76% |
2014 | 307.05 Million EUR | 8.98% |
2013 | 281.75 Million EUR | -27.04% |
2012 | 386.19 Million EUR | -22.45% |
2011 | 498.01 Million EUR | -5.72% |
2010 | 528.2 Million EUR | 10.13% |
2009 | 479.64 Million EUR | -5.86% |
2008 | 509.52 Million EUR | 57.05% |
2007 | 324.43 Million EUR | 21.57% |
2006 | 266.86 Million EUR | 31.62% |
2005 | 202.75 Million EUR | -41.27% |
2004 | 345.21 Million EUR | -31.03% |
2003 | 500.56 Million EUR | -27.47% |
2002 | 690.15 Million EUR | -9.72% |
2001 | 764.47 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 596.15 Million EUR | 0.0% |
2023 FY | 597.52 Million EUR | -4.23% |
2023 Q2 | 610.24 Million EUR | 0.0% |
2023 Q4 | 597.52 Million EUR | 0.0% |
2022 FY | 623.89 Million EUR | 14.26% |
2022 Q2 | 550.05 Million EUR | 0.0% |
2022 Q4 | 623.89 Million EUR | 0.0% |
2021 Q4 | 546.05 Million EUR | 0.0% |
2021 Q2 | 489.12 Million EUR | 0.0% |
2021 FY | 546.05 Million EUR | 6.86% |
2020 Q4 | 510.99 Million EUR | 0.0% |
2020 FY | 510.99 Million EUR | 20.2% |
2020 Q2 | 440.9 Million EUR | 0.0% |
2019 Q2 | 392.33 Million EUR | 0.0% |
2019 FY | 425.11 Million EUR | 4.39% |
2019 Q4 | 425.11 Million EUR | 0.0% |
2018 Q2 | 358.49 Million EUR | 0.0% |
2018 FY | 407.24 Million EUR | 22.47% |
2018 Q4 | 407.24 Million EUR | 0.0% |
2017 Q4 | 332.51 Million EUR | 0.0% |
2017 FY | 332.51 Million EUR | -12.64% |
2017 Q2 | 363 Million EUR | 0.0% |
2016 Q2 | 371.78 Million EUR | 0.0% |
2016 FY | 380.61 Million EUR | -3.73% |
2016 Q4 | 380.61 Million EUR | 0.0% |
2015 FY | 395.35 Million EUR | 28.76% |
2015 Q2 | 328.37 Million EUR | 0.0% |
2015 Q4 | 395.35 Million EUR | 0.0% |
2014 FY | 307.05 Million EUR | 8.98% |
2014 Q4 | 307.05 Million EUR | 0.0% |
2014 Q2 | 298.63 Million EUR | 0.0% |
2013 Q2 | 335.06 Million EUR | 0.0% |
2013 Q4 | 281.75 Million EUR | 0.0% |
2013 FY | 281.75 Million EUR | -27.04% |
2012 Q2 | 413.27 Million EUR | 0.0% |
2012 Q4 | 386.19 Million EUR | 0.0% |
2012 FY | 386.19 Million EUR | -22.45% |
2011 Q4 | 498.01 Million EUR | 0.0% |
2011 FY | 498.01 Million EUR | -5.72% |
2011 Q2 | 567.76 Million EUR | 0.0% |
2010 Q2 | 533.98 Million EUR | 0.0% |
2010 FY | 528.2 Million EUR | 10.13% |
2010 Q4 | 528.2 Million EUR | 0.0% |
2009 FY | 479.64 Million EUR | -5.86% |
2009 Q4 | 479.64 Million EUR | 0.0% |
2008 FY | 509.52 Million EUR | 57.05% |
2007 FY | 324.43 Million EUR | 21.57% |
2006 FY | 266.86 Million EUR | 31.62% |
2005 FY | 202.75 Million EUR | -41.27% |
2004 FY | 345.21 Million EUR | -31.03% |
2003 FY | 500.56 Million EUR | -27.47% |
2002 FY | 690.15 Million EUR | -9.72% |
2001 FY | 764.47 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Affluent Medical SA | 56.62 Million EUR | -955.274% |
Bluelinea Société Anonyme | 13.16 Million EUR | -4438.855% |
Carmat SA | 53.06 Million EUR | -1025.945% |
Diagnostic Medical Systems S.A. | 51.13 Million EUR | -1068.462% |
Euromedis Groupe | 46.25 Million EUR | -1191.717% |
Eurobio Scientific Société anonyme | 315.81 Million EUR | -89.202% |
Ikonisys S.A. | 20.85 Million EUR | -2765.486% |
Implanet S.A. | 10.63 Million EUR | -5517.449% |
Median Technologies SA | 35.81 Million EUR | -1568.513% |
SpineGuard SA | 11.03 Million EUR | -5314.672% |
Theraclion SA | 18.66 Million EUR | -3101.574% |
Euroapi S.A. | 1.61 Billion EUR | 62.942% |
Guerbet SA | 1.02 Billion EUR | 41.718% |
Koninklijke Philips N.V. | 29.7 Billion EUR | 97.988% |
Sequana Medical NV | 10.1 Million EUR | -5815.513% |